Literature DB >> 17188501

Blood-brain barrier disruption results in delayed functional and structural alterations in the rat neocortex.

O Tomkins1, O Friedman, S Ivens, C Reiffurth, S Major, J P Dreier, U Heinemann, A Friedman.   

Abstract

Disruption of the blood-brain barrier (BBB) is a characteristic finding in common neurological disorders. Human data suggest BBB disruption may underlie cerebral dysfunction. Animal experiments show the development of epileptiform activity following BBB breakdown. In the present study we investigated the neurophysiological, structural and functional consequences of BBB disruption. Adult rats underwent focal BBB disruption in the rat sensory-motor cortex using the bile salt sodium deoxycholate (DOC). Magnetic resonance imaging in-vivo showed an early BBB disruption with delayed reduction in cortical volume. This was associated with a reduced number of neurons and an increased number of astrocytes. In-vitro experiments showed that the threshold for spreading depression and the propagation velocity of the evoked epileptic potentials were increased 1 month after treatment. Furthermore, animals' motor functions deteriorated during the first few weeks following BBB disruption. Treatment with serum albumin resulted in a similar cell loss confirming that the effect of DOC was due to opening of the BBB. Our findings suggest that delayed neurodegeneration and functional impairment occur following the development of the epileptic focus in the BBB-permeable cerebral cortex.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17188501     DOI: 10.1016/j.nbd.2006.10.006

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  61 in total

Review 1.  Blood-brain barrier dysfunction, TGFβ signaling, and astrocyte dysfunction in epilepsy.

Authors:  Uwe Heinemann; Daniela Kaufer; Alon Friedman
Journal:  Glia       Date:  2012-02-29       Impact factor: 7.452

2.  Neuregulin-1 effects on endothelial and blood-brain-barrier permeability after experimental injury.

Authors:  Josephine Lok; Song Zhao; Wendy Leung; Ji Hae Seo; Deepti Navaratna; Xiaoying Wang; Michael J Whalen; Eng H Lo
Journal:  Transl Stroke Res       Date:  2012-04-13       Impact factor: 6.829

3.  Albumin induces excitatory synaptogenesis through astrocytic TGF-β/ALK5 signaling in a model of acquired epilepsy following blood-brain barrier dysfunction.

Authors:  Itai Weissberg; Lydia Wood; Lyn Kamintsky; Oscar Vazquez; Dan Z Milikovsky; Allyson Alexander; Hannah Oppenheim; Carolyn Ardizzone; Albert Becker; Federica Frigerio; Annamaria Vezzani; Marion S Buckwalter; John R Huguenard; Alon Friedman; Daniela Kaufer
Journal:  Neurobiol Dis       Date:  2015-03-30       Impact factor: 5.996

4.  VEGF as a target for neuroprotection.

Authors:  Annamaria Vezzani
Journal:  Epilepsy Curr       Date:  2008 Sep-Oct       Impact factor: 7.500

5.  Losartan prevents acquired epilepsy via TGF-β signaling suppression.

Authors:  Guy Bar-Klein; Luisa P Cacheaux; Lyn Kamintsky; Ofer Prager; Itai Weissberg; Karl Schoknecht; Paul Cheng; Soo Young Kim; Lydia Wood; Uwe Heinemann; Daniela Kaufer; Alon Friedman
Journal:  Ann Neurol       Date:  2014-05-28       Impact factor: 10.422

6.  Thrombin: is it on a par with seizures and epilepsy?

Authors:  Kevin M Kelly
Journal:  Epilepsy Curr       Date:  2008 Jul-Aug       Impact factor: 7.500

7.  Contribution of protease-activated receptor 1 in status epilepticus-induced epileptogenesis.

Authors:  D Isaev; I Lushnikova; O Lunko; O Zapukhliak; O Maximyuk; A Romanov; G G Skibo; C Tian; G L Holmes; E Isaeva
Journal:  Neurobiol Dis       Date:  2015-04-02       Impact factor: 5.996

Review 8.  Blood-brain barrier imaging in human neuropathologies.

Authors:  Ronel Veksler; Ilan Shelef; Alon Friedman
Journal:  Arch Med Res       Date:  2014-11-29       Impact factor: 2.235

Review 9.  Blood-brain barrier dysfunction and epilepsy: pathophysiologic role and therapeutic approaches.

Authors:  Nicola Marchi; Tiziana Granata; Chaitali Ghosh; Damir Janigro
Journal:  Epilepsia       Date:  2012-08-20       Impact factor: 5.864

10.  Breaching the blood-brain barrier as a gate to psychiatric disorder.

Authors:  Hadar Shalev; Yonatan Serlin; Alon Friedman
Journal:  Cardiovasc Psychiatry Neurol       Date:  2009-08-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.